This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Company. Active years: 1979.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1979
Title: Roger F Saintonge: Innovator in Pharmaceutical Chemistry
Introduction
Roger F Saintonge is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds that serve as intermediates in the preparation of anti-ulcer agents. His work has implications for improving therapeutic options in the medical field.
Latest Patents
Roger F Saintonge holds a patent for N,N'-[Bis(N-cyanoguanyl)]cystamine derivatives. This patent describes novel compounds characterized by a specific formula, wherein each R¹ is a straight or branched chain alkynyl group containing from 3 to 9 carbon atoms. These compounds are prepared by reacting cystamine with an N-cyano-N'-alkynyl-S-methylisothiourea, making them valuable in the pharmaceutical industry.
Career Highlights
Throughout his career, Roger has been associated with Bristol-Myers Company, where he has contributed to various research initiatives. His expertise in chemical compounds has positioned him as a key figure in the development of innovative solutions for health-related challenges.
Collaborations
Roger has worked alongside notable colleagues such as Ronnie R Crenshaw and Gerry Kavadias. Their collaborative efforts have further advanced the research and development of pharmaceutical compounds.
Conclusion
Roger F Saintonge's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his importance in the field. His work continues to influence the development of effective medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile